novartis oncology strives to become the world's premier oncology business by consistently discoveringking novel therapies that may improve and extend the lives of people living with cancer. and by incyte corporation. incyte's vision is to become a leading biopharmaceutical company focused on improving the lives of patients with serious unmet medical needs. additional funding provided by: abbott. ironwood pharmaceuticals. janssen pharmaceuticals inc. and by w.l. gore and associates. >> mcfarland: nearly 50,000 people die each year from all types of aortic disease, more than breast cancer or aids or even motor vehicle accidents. but despite this large number, many people have never heard of thoracic or abdominal aortic aneurysms, and therefore they have no idea how to recognize the signs that a potentially life-threatening rupture may be about to occur. >> kind of lucky, isn't it? [laughs] >> yes. >> mcfarland: dr. michel makaroun is professor of surgery and the chair of vascular surgery at university of pittsburgh medical center. >> the aorta is a very large blood vessel. this is the m